Wai Chun Bio-Technology Limited (HKG:0660)

Wai Chun Bio-Technology Revenue

Wai Chun Bio-Technology had revenue of 161.06M HKD in the half year ending December 31, 2024, a decrease of -60.24%. This brings the company's revenue in the last twelve months to 340.80M, down -39.02% year-over-year. In the fiscal year ending June 30, 2024, Wai Chun Bio-Technology had annual revenue of 370.07M, down -52.17%.

• Revenue (ttm): 340.80M
• Revenue Growth: -39.02%
• P/S Ratio: 0.05
• Revenue / Employee: 2.77M
• Employees: 140
• Market Cap: 15.35M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	370.07M	-403.59M	-52.17%
Jun 30, 2023	773.65M	102.20M	15.22%
Jun 30, 2022	671.46M	176.08M	35.54%
Dec 31, 2021	495.38M	-72.18M	-12.72%
Dec 31, 2020	567.55M	-11.68M	-2.02%